The Role of Dexmedetomidine in Pediatric Patients Presenting with an Anticholinergic Toxidrome
Background. We report two pediatric cases of anticholinergic toxidrome, including the youngest reported to date, in which standard therapeutic strategies were either contraindicated or ineffective, while treatment with dexmedetomidine was rapidly efficacious with no adverse effects. Moreover, with t...
Saved in:
Main Authors: | Mitchell Zekhtser, Erin Carroll, Molly Boyd, Shashikanth Ambati |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Critical Care |
Online Access: | http://dx.doi.org/10.1155/2021/7590960 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mini Review: Anticholinergic Activity as a Behavioral Pathology of Lewy Body Disease and Proposal of the Concept of “Anticholinergic Spectrum Disorders”
by: Koji Hori, et al.
Published: (2016-01-01) -
Anticholinergic burden and behavioral and psychological symptoms in older patients with cognitive impairment
by: Sabrina Pistorio, et al.
Published: (2025-02-01) -
Assessing the health implications of anticholinergic drugs in older people
by: Mariangela Boccardi, et al.
Published: (2025-01-01) -
Myasthenia Gravis Masquerading as Status Asthmaticus
by: Neha Pirwani, et al.
Published: (2021-01-01) -
Investigation of the total anticholinergic load of reported anticholinergic drug-related adverse events using the Japanese adverse drug event report database: a retrospective pharmacovigilance study
by: Yusuke Kan, et al.
Published: (2025-01-01)